186 related articles for article (PubMed ID: 23377752)
21. The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model.
San Román B; De Andrés X; Muñoz PM; Obregón P; Asensio AC; Garrido V; Mansilla C; Arribillaga L; Lasarte JJ; De Andrés D; Amorena B; Grilló MJ
Vaccine; 2012 Mar; 30(15):2564-9. PubMed ID: 22326778
[TBL] [Abstract][Full Text] [Related]
22. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.
Lee SE; Kim SY; Jeong BC; Kim YR; Bae SJ; Ahn OS; Lee JJ; Song HC; Kim JM; Choy HE; Chung SS; Kweon MN; Rhee JH
Infect Immun; 2006 Jan; 74(1):694-702. PubMed ID: 16369026
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice.
Gonzalez-Rabade N; McGowan EG; Zhou F; McCabe MS; Bock R; Dix PJ; Gray JC; Ma JK
Plant Biotechnol J; 2011 Aug; 9(6):629-38. PubMed ID: 21443546
[TBL] [Abstract][Full Text] [Related]
24. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
25. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
Honko AN; Sriranganathan N; Lees CJ; Mizel SB
Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
[TBL] [Abstract][Full Text] [Related]
26. Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
Koopman G; Bogers WM; van Gils M; Koornstra W; Barnett S; Morein B; Lehner T; Heeney JL
J Med Virol; 2007 May; 79(5):474-82. PubMed ID: 17385685
[TBL] [Abstract][Full Text] [Related]
27. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
[TBL] [Abstract][Full Text] [Related]
28. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
[TBL] [Abstract][Full Text] [Related]
29. A rationally designed flagellin-L2 fusion protein induced serum and mucosal neutralizing antibodies against multiple HPV types.
Zhang T; Chen X; Liu H; Bao Q; Wang Z; Liao G; Xu X
Vaccine; 2019 Jul; 37(30):4022-4030. PubMed ID: 31213378
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
[TBL] [Abstract][Full Text] [Related]
31. Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.
Wang BZ; Xu R; Quan FS; Kang SM; Wang L; Compans RW
PLoS One; 2010 Nov; 5(11):e13972. PubMed ID: 21124769
[TBL] [Abstract][Full Text] [Related]
32. Display of FliC131 on the Surface of Lactococcus lactis as a Strategy to Increase its Adjuvanticity for Mucosal Immunization.
Silvestre D; Moreno G; Argüelles MH; Tomás Fariña J; Biedma ME; Peri Ibáñez ES; Mandile MG; Glikmann G; Rumbo M; Castello AA; Temprana CF
J Pharm Sci; 2024 Jul; 113(7):1794-1803. PubMed ID: 38522753
[TBL] [Abstract][Full Text] [Related]
33. A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity.
Khademi F; Derakhshan M; Yousefi-Avarvand A; Najafi A; Tafaghodi M
Microb Pathog; 2018 Dec; 125():507-513. PubMed ID: 30352265
[TBL] [Abstract][Full Text] [Related]
34. CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
Sundling C; Schön K; Mörner A; Forsell MNE; Wyatt RT; Thorstensson R; Hedestam GBK; Lycke NY
J Gen Virol; 2008 Dec; 89(Pt 12):2954-2964. PubMed ID: 19008380
[TBL] [Abstract][Full Text] [Related]
35. Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice.
Yoshizawa I; Mizuochi T; Ogata A; Murakami M; Yagita H; Takahashi Y; Mizuochi T; Takemori T; Tsunetsugu-Yokota Y
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):469-79. PubMed ID: 12882656
[TBL] [Abstract][Full Text] [Related]
36. Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice.
Krupka M; Zachova K; Cahlikova R; Vrbkova J; Novak Z; Sebela M; Weigl E; Raska M
Immunol Lett; 2015 Jul; 166(1):36-44. PubMed ID: 26021827
[TBL] [Abstract][Full Text] [Related]
37. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
38. Flagellin-PAc Fusion Protein Inhibits Progression of Established Caries.
Bao R; Yang JY; Sun Y; Zhou DH; Yang Y; Li YM; Cao Y; Xiao Y; Li W; Yu J; Zhao BL; Zhong MH; Yan HM
J Dent Res; 2015 Jul; 94(7):955-60. PubMed ID: 25883108
[TBL] [Abstract][Full Text] [Related]
39. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
[TBL] [Abstract][Full Text] [Related]
40. Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.
Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
Med Microbiol Immunol; 2019 Feb; 208(1):89-100. PubMed ID: 30209565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
